Publications (155) Eduardo Pinar Bermudez publications

filter_list

2025

  1. Final 5-year outcomes of the Epic02 – RANGO study: A real-world registry of the durable fluoroacrylate polymer-based sirolimus-eluting Angiolite® stent

    Cardiovascular Revascularization Medicine

  2. Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 338-346

  3. Impact of lesion hemodynamic pattern and calcium morphology on the functional efficacy of coronary intravascular lithotripsy

    Cardiovascular Revascularization Medicine

  4. Nuevo balón scoring para el tratamiento de lesiones coronarias con calcificación de moderada a grave. Primer estudio en humanos Naviscore

    REC: Interventional Cardiology, Vol. 7, Núm. 2, pp. 91-98

  5. Surgical Bailout in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Incidence, Trends, and Clinical Outcomes

    JACC: Cardiovascular Interventions, Vol. 18, Núm. 1, pp. 89-99

2024

  1. Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 22, pp. 2664-2677

  2. Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial

    European Journal of Internal Medicine, Vol. 126, pp. 89-94

  3. Coronary physiology: an essential diagnostic tool beyond obtaining a cutoff point

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 896-898

  4. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  5. Impact of coronary calcium morphology on intravascular lithotripsy

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 10, pp. e656-e668

  6. OPTImized coronary interventions eXplaIn the bEst cliNical outcomEs (OPTI-XIENCE) study. Rationale and study design

    Cardiovascular Revascularization Medicine, Vol. 59, pp. 93-98

  7. Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 24, pp. 2866-2874

  8. Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 771-782

2023

  1. Accuracy of the angiography-based quantitative flow ratio in intermediate left main coronary artery lesions and comparison with visual estimation

    International Journal of Cardiology, Vol. 383, pp. 8-14

  2. Cost-effectiveness analysis of dyevert™ Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain

    Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 2, pp. 233-240

  3. Coste-efectividad del implante percutáneo de válvula aórtica con SAPIEN 3 en pacientes con bajo riesgo de mortalidad quirúrgica en España

    REC: Interventional Cardiology, Vol. 5, Núm. 1, pp. 38-45

  4. Evaluación de los resultados en salud del implante valvular aórtico transcatéter en una cohorte de pacientes según su perfil de riesgo

    REC: Interventional Cardiology, Vol. 5, Núm. 2, pp. 102-109

  5. Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)

    Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5

2022

  1. Amphilimus- Versus Everolimus-Eluting Stents in Patients With Diabetes Mellitus: 5-Year Follow-Up of the RESERVOIR Trial

    Cardiovascular Revascularization Medicine

  2. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330